153 related articles for article (PubMed ID: 28360822)
1. Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study.
Gerotziafas GT; Van Dreden P; Mathieu d'Argent E; Lefkou E; Grusse M; Comtet M; Sangare R; Ketatni H; Larsen AK; Elalamy I
Thromb J; 2017; 15():9. PubMed ID: 28360822
[TBL] [Abstract][Full Text] [Related]
2. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.
Syrigos K; Grapsa D; Sangare R; Evmorfiadis I; Larsen AK; Van Dreden P; Boura P; Charpidou A; Kotteas E; Sergentanis TN; Elalamy I; Falanga A; Gerotziafas GT
Oncologist; 2018 Nov; 23(11):1372-1381. PubMed ID: 30104289
[TBL] [Abstract][Full Text] [Related]
3. Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study.
Gerotziafas GT; Zografos T; Pantos I; Lefkou E; Carlo A; Fareed J; Van Dreden P; Katritsis D
Clin Appl Thromb Hemost; 2020; 26():1076029620964590. PubMed ID: 33284037
[TBL] [Abstract][Full Text] [Related]
4. Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.
Fotiou D; Sergentanis TN; Papageorgiou L; Stamatelopoulos K; Gavriatopoulou M; Kastritis E; Psaltopoulou T; Salta S; Van Dreden P; Sangare R; Larsen AK; Terpos E; Elalamy I; Dimopoulos MA; Gerotziafas GT
Blood Cancer J; 2018 Nov; 8(11):102. PubMed ID: 30405097
[TBL] [Abstract][Full Text] [Related]
5. Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.
Chaari M; Ayadi I; Rousseau A; Lefkou E; Van Dreden P; Sidibe F; Ketatni H; Galea V; Khaterchi A; Bouzguenda R; Frikha M; Ghorbal L; Daoud J; Kallel C; Quinn M; Gligorov J; Lotz JP; Hatmi M; Elalamy I; Gerotziafas GT
BMC Cancer; 2014 Dec; 14():991. PubMed ID: 25535397
[TBL] [Abstract][Full Text] [Related]
6. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
[TBL] [Abstract][Full Text] [Related]
7. An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy.
Balandina AN; Koltsova EM; Teterina TA; Yakovenko AG; Simonenko EU; Poletaev AV; Zorina IV; Shibeko AM; Vuimo TA; Yakovenko SA; Ataullakhanov FI
PLoS One; 2019; 14(5):e0216724. PubMed ID: 31120933
[TBL] [Abstract][Full Text] [Related]
8. Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure.
Van Dreden P; Woodhams B; Rousseau A; Dreyfus JF; Vasse M
Clin Chem Lab Med; 2013 Feb; 51(2):387-96. PubMed ID: 23096108
[TBL] [Abstract][Full Text] [Related]
9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
10. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
12. PO-53 - Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study.
Boura P; Evmorfiadis I; Rousseau A; Charpidou A; Giozos G; Van Dreden P; Syrigos K; Larsen A; Elalamy I; Gerotziafas GT
Thromb Res; 2016 Apr; 140 Suppl 1():S196. PubMed ID: 27161741
[TBL] [Abstract][Full Text] [Related]
13. Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional study.
Lentschener C; Flaujac C; Ibrahim F; Gouin-Thibault I; Bazin M; Sogni P; Samama CM
Eur J Anaesthesiol; 2016 Feb; 33(2):126-33. PubMed ID: 26258657
[TBL] [Abstract][Full Text] [Related]
14. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
16. Detection of endometrial and subendometrial vasculature on the day of embryo transfer and prediction of pregnancy during fresh in vitro fertilization cycles.
Kim A; Jung H; Choi WJ; Hong SN; Kim HY
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):360-5. PubMed ID: 25286791
[TBL] [Abstract][Full Text] [Related]
17. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis.
Tamura H; Yoshida H; Kikuchi H; Josaki M; Mihara Y; Shirafuta Y; Shinagawa M; Tamura I; Taketani T; Takasaki A; Sugino N
J Ovarian Res; 2019 Dec; 12(1):123. PubMed ID: 31831028
[TBL] [Abstract][Full Text] [Related]
18. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study.
Mendoza-Tesarik R; Mendoza N; López CC; Tesarik J
Reprod Biomed Online; 2019 Aug; 39(2):225-230. PubMed ID: 31178369
[TBL] [Abstract][Full Text] [Related]
19. Platelets compensate for poor thrombin generation in type 3 von Willebrand disease.
Szanto T; Nummi V; Jouppila A; Brinkman HJM; Lassila R
Platelets; 2020; 31(1):103-111. PubMed ID: 30836803
[TBL] [Abstract][Full Text] [Related]
20. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
